Related Experiment Video
Updated: Jun 22, 2026

Development of Recombinant Proteins to Treat Chronic Pain
Published on: April 11, 2018
[Epidemiology and pathophysiology of pain--new targets for pain therapy]
1Institut für Physiologie 1/Neurophysiologie, Universitätskinikum Jena, Teichgraben 8, 07743 Jena. Hans-Georg.Schaible@mti.uni-jena.de
Abstract:
Although effective drugs are available to fight pain numerous people suffer from chronic pain. Chronic pain most often occurs in the skeletomuscular system, i.e., in deep somatic tissue. In order to improve pain treatment it is necessary to develop new approaches for therapy. These are expected from the results of basic research on molecular mechanisms of nociception, from insights into the pathophysiological generation of pain and from the better understanding of pain processing in the central nervous system. Therapeutical options are supposed to be found in influencing the peripheral transduction mechanisms for noxious stimuli, in antagonising of peripherally acting algesic mediators and in attenuating synaptic processes in the central nervous nociceptive system. Examples for new targets are TRPV1 receptors, cytokine receptors, neuropeptide receptors, glutamate receptors, sodium- and calcium channels. In addition, the better understanding of neuronal mechanisms of placebo effects may open new pathways.
Insights
Despite available pain medications, chronic pain persists, particularly in musculoskeletal tissues. New therapeutic strategies targeting molecular pain mechanisms and central nervous system processing are crucial for improved pain management.
Area of Science:
- Neuroscience
- Molecular Biology
- Pharmacology
Context:
- Chronic pain affects numerous individuals, often originating in the musculoskeletal system.
- Existing pain medications are insufficient for many suffering from persistent pain.
- Novel therapeutic approaches are needed to address the complex nature of chronic pain.
Purpose:
- To explore new therapeutic targets for chronic pain management.
- To investigate molecular mechanisms underlying nociception and pain processing.
- To identify strategies for improving pain treatment by understanding pathophysiological pain generation.
Summary:
- Research into molecular mechanisms of nociception and central nervous system pain processing is vital.
- Therapeutic strategies may involve modulating peripheral transduction, antagonizing algesic mediators, and attenuating central synaptic processes.
- Potential new targets include TRPV1 receptors, cytokine and neuropeptide receptors, glutamate receptors, and ion channels.
Impact:
- Advances in understanding pain mechanisms can lead to the development of more effective pain therapies.
- Identifying novel drug targets offers hope for improved management of chronic pain conditions.
- Exploring neuronal mechanisms of placebo effects may reveal new therapeutic pathways.
Related Concept Videos
Analgesia and Pain Management
Pain
Nociception
Pharmacogenomics: Identification of New Drug Targets
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
